These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25476855)

  • 1. Augmented TGFβ receptor signaling induces apoptosis of pancreatic carcinoma cells.
    Li C; Zhao Z; Zhou Z; Liu R
    Tumour Biol; 2015 Apr; 36(4):2815-9. PubMed ID: 25476855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β receptor signaling restrains growth of pancreatic carcinoma cells.
    Zhao Z; Xi H; Xu D; Li C
    Tumour Biol; 2015 Sep; 36(10):7711-6. PubMed ID: 25934336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
    Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
    Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.
    Pickup MW; Owens P; Gorska AE; Chytil A; Ye F; Shi C; Weaver VM; Kalluri R; Moses HL; Novitskiy SV
    Cancer Immunol Res; 2017 Sep; 5(9):718-729. PubMed ID: 28775207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
    Craven KE; Gore J; Wilson JL; Korc M
    Oncotarget; 2016 Jan; 7(1):323-41. PubMed ID: 26586478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.
    Song W; Wang L; Wang L; Li Q
    Tumour Biol; 2015 Jun; 36(6):4741-5. PubMed ID: 25623117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ signaling in pancreatic ductal adenocarcinoma.
    Zhang H; Liu C; Kong Y; Huang H; Wang C; Zhang H
    Tumour Biol; 2015 Mar; 36(3):1613-8. PubMed ID: 25355597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
    Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
    BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.
    Inaguma S; Ito H; Riku M; Ikeda H; Kasai K
    Oncotarget; 2015 Sep; 6(29):28257-68. PubMed ID: 26318045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer.
    Principe DR; Park A; Dorman MJ; Kumar S; Viswakarma N; Rubin J; Torres C; McKinney R; Munshi HG; Grippo PJ; Rana A
    Mol Cancer Ther; 2019 Mar; 18(3):613-620. PubMed ID: 30587556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer.
    Cases AI; Ohtsuka T; Kimura H; Zheng B; Shindo K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Oncol Rep; 2015 Oct; 34(4):1717-25. PubMed ID: 26238361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
    Li Z; Lin P; Gao C; Peng C; Liu S; Gao H; Wang B; Wang J; Niu J; Niu W
    Tumour Biol; 2016 Apr; 37(4):5117-31. PubMed ID: 26547582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.
    Oshima H; Nakayama M; Han TS; Naoi K; Ju X; Maeda Y; Robine S; Tsuchiya K; Sato T; Sato H; Taketo MM; Oshima M
    Cancer Res; 2015 Feb; 75(4):766-76. PubMed ID: 25687406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.